-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$52.1715.06% Upside
Revolution Medicines, Inc. Frequently Asked Questions
-
What analysts cover Revolution Medicines, Inc.?
Revolution Medicines, Inc. has been rated by research analysts at Piper Sandler, Needham, Wedbush, Stifel Nicolaus, Oppenheimer, Raymond James in the past 90 days.